Document Details

Form
6-K
Filing Date
Dec 20, 2022
Document Date
Dec 20, 2022
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
BioLineRx
Issuer
BioLineRx Ltd.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Shape
Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients

Discover our Pipeline